Search

Filters
Clear All
  • 15
  • 52
  • 2
  • 647

Phase

  • 1
  • 11
  • 14
  • 47
  • 7
  • 66
  • 6
  • 541
  • 654
  • 299

Found 716 All Conditions trials

A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

M
Mohammed Madmani, MD
R
Rolf Kreutz, MD
18 years and older
All genders
Phase 3
Interventional
This study will randomize patients recently discharged from the hospital with a confirmed diagnosis of type 1 acute myocardial infarction (Thygesen et al. 2018) and having additionaldiovascular risk factors.
B
Bradley N. Bohnstedt, MD
18-80 years
All genders
Interventional
The purpose of this study is to gather preliminary safety and effectiveness data on Citadelbolization Device in the treatment of wide-neck intracranial aneurysms.
R
Raghu Motaganahalli, MD
18-79 years
All genders
Observational
The study objective is to evaluate real world usage of the ENROUTE Transcarotid Stent when used with the ENROUTE Transcarotid Neuroprotection System in patients at standard risk fordverse events from carotid endarterectomy
M
Myda Khalid
9-21 years
All genders
Phase 3
Interventional
The objective of this study is to determine if early high volume intravenous fluiddministration (hyperhydration) may be effective in mitigating or preventing complications ofhiga toxin-producing E. coli (STEC) infection in children and adolescents when compared withditional approaches (conservative fluid management).
J
John Fuqua, MD
2-10 years
All genders
Phase 3
Interventional
The study compares two medicines for treatment of children born small and who stay small, or with Turner Syndrome, Noonan Syndrome, or idiopathic short stature. The purpose of the studyhow well treatment with somapacitan works compared to treatment with Norditropin®.w medicine, and Norditropin® is a medicine doctors can already prescribeuntries. …
H
Heba Ismail
11-18 years
All genders
Phase 2
Interventional
Obesity prevalence in persons with T1D has increased, which further complicates managementd risk for complications. The proposed study is relevant to public health because it helps us understand the role of the gut microbiome in disease pathophysiology in T1D youth withbesity as well as potential mechanisms to modify disease.
J
Jason Mackey
18 years and older
All genders
Observational
The overall goal of the DISCOVERY study is to better understand what factors contribute tohanges in cognitive (i.e., thinking and memory) abilities in patients who experienced ake. The purpose of the study is to help doctors identify patients at risk for dementia (decline in memory, thinking and other mental abilities …
M
Marwan Ghabril
18-85 years
All genders
Phase 3
Interventional
Study RNLC3131 is a Phase 3, randomized, double-blind, placebo-controlled, multicenter studyhe efficacy and safety of rifaximin SSD-40mg IR for the delay of the first episodevert hepatic encephalopathy (OHE) decompensation in liver cirrhosis, defined by thedically controlled ascites.
J
Jesse Savage, MD
60 years and older
All genders
Interventional
The Placebo-Controlled Efficacy in Idiopathic Normal Pressure Hydrocephalus (iNPH) Shunting (PENS) trial is a multi-center blinded, randomized, placebo-controlled design investigationbrospinal fluid (CSF) shunt surgery to study the shunt efficacy in iNPH patients.
M
Melissa Lah, MD
All genders
Phase 3
Interventional
The main purpose of this study is to evaluate the long-term safety of PTC923 in participants with phenylketonuria, and to evaluate the changes from baseline in dietary phenylalanine (Phe)/protein consumption.
591 - 600 of 716